心血管疾患伴发急性肾功能衰竭及多脏器功能衰竭的救治及预后  

The treatment and prognosis of acute renal failure and multiple organs failure in the cardiovascular patients

作　　者：吴华[1] 汤天清[2] 毛永辉[2] 孙福成[2] 徐中武[2] 

机构地区：[1]卫生部北京医院肾内科 [2]卫生部北京医院,北京100730

出　　处：《中国心血管杂志》2001年第4期210-212,共3页Chinese Journal of Cardiovascular Medicine

摘　　要：目的 回顾性分析心血管疾病伴发急性肾功能衰竭及多脏器功能衰竭的病因、治疗及预后。方法14例患者主要因急性心肌梗死、心肺复苏后、心脏手术后、冠状动脉造影后发生急性肾功能衰竭或多脏器功能衰竭,进行肾脏替代疗法。结果 14例患者5例存活,9例死亡,病死率64.3％;其中7例伴糖尿病者,6例死亡;急性心肌梗死后7例患者4例死亡,心脏手术后4例患者3例死亡;死亡主要与器官衰竭数目相关。结论心血管疾病伴发急性肾功能衰竭及多脏器功能衰竭经肾脏替代疗法及血流动力学监测,有助于体液平衡,稳定心血管系统,是安全有效的治疗方法。Objective To study retrospectively the treatment and prognosis in the cardiovascular patients with acute renal failure (ARF) and multiple organs failure(MOF). Methods 14 patients with ARF and MOF mainly from a-cute myocardium infarction and cardiac surgery were treated by continuous or intermittent renal replacement therapy. Results The overall mortality was 65. 3%, in which the major cause of death was MOF and with diabetes. Conclusion Renal replacement therapy and hemodynamics monitor can be considered as a safe and effective artificial renal support in the patients with ARF and MOF as a complication of AMI and cardiac surgery, it can be beneficial to maintenance of the body water balance and to stability of cardiovascular system.

关 键 词：心血管疾病 急性肾功能衰竭 多脏器功能衰竭 肾脏替代疗法 

分 类 号：R54[医药卫生—心血管疾病]